It's How Medicine Should Be®


French German Italian Portuguese Russian

Bridge Study: Bridging Anticoagulation

Clinical Trial Title: 
Bridge: Bridging Anticoagulation for Patients with Atrial Fibrillation
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Stuart W. Rosenbush, MD
Clinical Trial Protocol Description: 

The Bridge study will determine whether a bridging blood thinner called dalteparin is helpful or harmful for people with atrial fibrillation who stop taking warfarin in preparation for surgery or another procedure.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are 18 years of age or older.
  • Have chronic atrial fibrillation.
  • Have been treated with Coumadin for at least three months.

This is a partial list of eligibility criteria. 

Clinical Trial Area: 
Heart and Vascular Conditions
Contact Phone: 
(312) 942-8144
Contact Name: 
Sherry Nelson